key: cord-0950779-y13zez3z
authors: Mohamed, R. A.; Junaideen, S. M.
title: Issues of Random Sampling with Rapid Antigen Tests for COVID-19 Diagnosis: A Special Reference to Kalmunai RDHS Division
date: 2021-01-20
journal: nan
DOI: 10.1101/2021.01.11.21249636
sha: 717fbe04186d11d08dd221a9d34cb58348d5c80b
doc_id: 950779
cord_uid: y13zez3z

Random sampling from the community and performing the rapid antigen test has become a debatable issue during this COVID-19 pandemic. This writing analyzes the concerns using the data from Kalmunai RDHS Division, Sri Lanka, related to COVID-19 and shows the issues of random sampling in a community wherein the incident rate is small. Therefore, suitable sampling protocol is to be developed for performing rapid antigen test for COVID-19 diagnosis. Keywords: COVID-19, random sampling, rapid antigen test, sensitivity, specificity

Random sampling for diagnosing is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 20, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 20, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 20, 2021. ; https://doi.org/10.1101/2021.01.11.21249636 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 20, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 were done randomly but in reality, it is not. 

There are large number of non-COVID-19 cases in the population (95.8%). Since the test has 97 % specificity, 3 % of the non-COVID-19 cases are falsely identified as case. This issue drastically reduces the reliability of the test to 53.8 % when one gets positive diagnosis. This reliability will go further down since the estimated incident rate was based on the assumption of random sampling which is not true in every case. Therefore, a suitable protocol is required for the sampling the mechanism when performing RATs in the community.

However, the figure 1 can't be an absolute example for question arisen that more tests-more positive since all sample were not obtained at random and PCR tests were also used for the diagnosis. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 20, 2021. ; https://doi.org/10. 1101 /2021 

Fast coronavirus tests: what they can and can't do

SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK. ECDC: Stockholm

Emergency Use Listing Procedure (EUL) open for in vitro diagnostics

Interim guidance on the use of rapid antigen detection tests for the identification of SARS-CoV-2 infection. Department of Public Health Services

Interim Guidance for Rapid Antigen Testing for SARSCoV-2. National Center for Immunization and Respiratory Diseases